Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Journal of Biopharmaceutical Statistics|March 26, 1999
Design and analysis issues for crossover designs in phase I clinical studiesP C Boon, K C Roes
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 1, 1997
Pharmacological treatment of severely depressed patients: a meta-analysis comparing efficacy of mirtazapine and amitriptylineS Kasper, M Zivkov, K C Roes, et al.
Sociology of Health & Illness|November 3, 2010
The impact of patient advocacy: the case of innovative breast cancer drug reimbursementRoel Nahuis, Wouter P C Boon
Drug Discovery Today|April 15, 2008
The role of users in innovation in the pharmaceutical industryRuud E H M Smits, Wouter P C Boon
Journal of Clinical Psychopharmacology|September 23, 2000
Mirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimensF S Radhakishun, J van den Bos, B C van der Heijden, et al.
BMC Public Health|April 30, 2022
Expert perspectives on the introduction of Triple Artemisinin-based Combination Therapies (TACTs) in Southeast Asia: a Delphi studyFreek de Haan, Wouter P C Boon, Chanaki Amaratunga, et al.
Environmental Innovation and Societal Transitions|February 2, 2022
Market Formation in a Global Health TransitionFreek de Haan, Ellen H M Moors, Arjen M Dondorp, et al.
Expert Review of Molecular Diagnostics|June 8, 2022
Impact of the new European Union In Vitro Diagnostics Regulation on the practice of hospital diagnostic laboratoriesAudrey M M Hermans, Marc Maliepaard, Wouter P C Boon, et al.
Pageof 4